Annual Operating Profit
-$18.70 M
+$28.77 M+60.61%
December 31, 2024
Summary
- As of February 28, 2025, ITRM annual operating income is -$18.70 million, with the most recent change of +$28.77 million (+60.61%) on December 31, 2024.
- During the last 3 years, ITRM annual operating profit has risen by +$5.84 million (+23.80%).
- ITRM annual operating profit is now -39.95% below its all-time high of -$13.36 million, reached on December 31, 2016.
Performance
ITRM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$3.67 M
+$1.22 M+24.90%
December 1, 2024
Summary
- As of February 28, 2025, ITRM quarterly operating income is -$3.67 million, with the most recent change of +$1.22 million (+24.90%) on December 1, 2024.
- Over the past year, ITRM quarterly operating profit has increased by +$1.22 million (+24.90%).
- ITRM quarterly operating profit is now at all-time high.
Performance
ITRM Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$18.70 M
+$7.76 M+29.33%
December 1, 2024
Summary
- As of February 28, 2025, ITRM TTM operating income is -$18.70 million, with the most recent change of +$7.76 million (+29.33%) on December 1, 2024.
- Over the past year, ITRM TTM operating profit has increased by +$7.76 million (+29.33%).
- ITRM TTM operating profit is now -237.35% below its all-time high of -$5.54 million, reached on March 31, 2017.
Performance
ITRM TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
ITRM Operating Profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +60.6% | +24.9% | +29.3% |
3 y3 years | +23.8% | +24.9% | +29.3% |
5 y5 years | +81.7% | +24.9% | +29.3% |
ITRM Operating Profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +60.6% | at high | +78.0% | at high | +60.6% |
5 y | 5-year | at high | +81.7% | at high | +84.2% | at high | +81.7% |
alltime | all time | -40.0% | +81.7% | at high | +88.2% | -237.3% | +81.8% |
Iterum Therapeutics Operating Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | -$18.70 M(-60.6%) | - | - |
Dec 2024 | - | -$3.67 M(-24.9%) | -$18.70 M(-29.3%) |
Sep 2024 | - | -$4.89 M(+22.9%) | -$26.46 M(-30.8%) |
Jun 2024 | - | -$3.98 M(-35.5%) | -$38.26 M(-15.2%) |
Mar 2024 | - | -$6.16 M(-46.1%) | -$45.10 M(-5.0%) |
Dec 2023 | -$47.47 M(+56.2%) | -$11.43 M(-31.5%) | -$47.47 M(+8.0%) |
Sep 2023 | - | -$16.68 M(+54.2%) | -$43.96 M(+28.1%) |
Jun 2023 | - | -$10.82 M(+26.9%) | -$34.31 M(+8.8%) |
Mar 2023 | - | -$8.53 M(+7.6%) | -$31.54 M(+3.8%) |
Dec 2022 | -$30.38 M(+23.8%) | -$7.93 M(+12.7%) | -$30.38 M(+3.7%) |
Sep 2022 | - | -$7.03 M(-12.6%) | -$29.29 M(+8.0%) |
Jun 2022 | - | -$8.05 M(+9.2%) | -$27.13 M(+4.1%) |
Mar 2022 | - | -$7.37 M(+8.0%) | -$26.06 M(+6.2%) |
Dec 2021 | -$24.54 M(-23.6%) | -$6.83 M(+40.1%) | -$24.54 M(+9.8%) |
Sep 2021 | - | -$4.87 M(-30.2%) | -$22.35 M(-6.1%) |
Jun 2021 | - | -$6.99 M(+19.5%) | -$23.81 M(-5.0%) |
Mar 2021 | - | -$5.85 M(+25.9%) | -$25.08 M(-21.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2020 | -$32.13 M(-68.5%) | -$4.64 M(-26.7%) | -$32.13 M(-36.6%) |
Sep 2020 | - | -$6.33 M(-23.2%) | -$50.66 M(-32.7%) |
Jun 2020 | - | -$8.25 M(-36.0%) | -$75.32 M(-20.2%) |
Mar 2020 | - | -$12.89 M(-44.4%) | -$94.45 M(-7.4%) |
Dec 2019 | -$102.02 M(+33.3%) | -$23.18 M(-25.2%) | -$102.02 M(-0.7%) |
Sep 2019 | - | -$31.00 M(+13.2%) | -$102.79 M(+6.2%) |
Jun 2019 | - | -$27.38 M(+33.8%) | -$96.77 M(+14.1%) |
Mar 2019 | - | -$20.47 M(-14.5%) | -$84.82 M(+10.8%) |
Dec 2018 | -$76.56 M(+159.9%) | -$23.94 M(-4.2%) | -$76.56 M(+23.8%) |
Sep 2018 | - | -$24.99 M(+62.0%) | -$61.82 M(+37.0%) |
Jun 2018 | - | -$15.43 M(+26.4%) | -$45.13 M(+25.0%) |
Mar 2018 | - | -$12.20 M(+32.6%) | -$36.12 M(+22.6%) |
Dec 2017 | -$29.45 M(+120.5%) | -$9.20 M(+10.9%) | -$29.45 M(+45.4%) |
Sep 2017 | - | -$8.30 M(+29.4%) | -$20.25 M(+69.4%) |
Jun 2017 | - | -$6.41 M(+15.7%) | -$11.96 M(+115.7%) |
Mar 2017 | - | -$5.54 M | -$5.54 M |
Dec 2016 | -$13.36 M | - | - |
FAQ
- What is Iterum Therapeutics annual operating income?
- What is the all time high annual operating profit for Iterum Therapeutics?
- What is Iterum Therapeutics annual operating profit year-on-year change?
- What is Iterum Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Iterum Therapeutics?
- What is Iterum Therapeutics quarterly operating profit year-on-year change?
- What is Iterum Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Iterum Therapeutics?
- What is Iterum Therapeutics TTM operating profit year-on-year change?
What is Iterum Therapeutics annual operating income?
The current annual operating profit of ITRM is -$18.70 M
What is the all time high annual operating profit for Iterum Therapeutics?
Iterum Therapeutics all-time high annual operating income is -$13.36 M
What is Iterum Therapeutics annual operating profit year-on-year change?
Over the past year, ITRM annual operating income has changed by +$28.77 M (+60.61%)
What is Iterum Therapeutics quarterly operating income?
The current quarterly operating profit of ITRM is -$3.67 M
What is the all time high quarterly operating profit for Iterum Therapeutics?
Iterum Therapeutics all-time high quarterly operating income is -$3.67 M
What is Iterum Therapeutics quarterly operating profit year-on-year change?
Over the past year, ITRM quarterly operating income has changed by +$1.22 M (+24.90%)
What is Iterum Therapeutics TTM operating income?
The current TTM operating profit of ITRM is -$18.70 M
What is the all time high TTM operating profit for Iterum Therapeutics?
Iterum Therapeutics all-time high TTM operating income is -$5.54 M
What is Iterum Therapeutics TTM operating profit year-on-year change?
Over the past year, ITRM TTM operating income has changed by +$7.76 M (+29.33%)